Effects of Pioglitazone for Secondary Stroke Prevention in Patients with Impaired Glucose Tolerance and Newly Diagnosed Diabetes: The J-SPIRIT Study-Reference-Cited by-同舟云学术

Effects of Pioglitazone for Secondary Stroke Prevention in Patients with Impaired Glucose Tolerance and Newly Diagnosed Diabetes: The J-SPIRIT Study

Published:2015 Issue:12 Volume:22 Page:1305-1316
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Tanaka Ryota¹,Yamashiro Kazuo¹,Okuma Yasuyuki²,Shimura Hideki³,Nakamura Shinichiro⁴,Ueno Yuji¹,Tanaka Yasutaka¹,Miyamoto Nobukazu²,Tomizawa Yuji²,Nakahara Toshiki⁴,Furukawa Yoshiaki⁴,Watada Hirotaka⁵,Kawamori Ryuzo⁵,Hattori Nobutaka¹,Urabe Takao³

Affiliation:

1. Department of Neurology, Juntendo University School of Medicine

2. Department of Neurology, Juntendo University Shizuoka Hospital

3. Department of Neurology, Juntendo University Urayasu Hospital

4. Department of Neurology, Juntendo Koto Geriatric Medical Center

5. Department of Metabolism and Endocrinology, Juntendo University School of Medicine

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry (medical),Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/22/12/22_30007/_pdf

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes;Biomedicines;2023-11-07

2. Association of Pioglitazone With Major Adverse Cardiovascular Events, All-Cause Mortality, and Heart Failure Hospitalizations: A Systematic Review;Cureus;2023-10-12

3. Insulin resistance estimated by estimated glucose disposal rate predicts outcomes in acute ischemic stroke patients;Cardiovascular Diabetology;2023-08-26

4. Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack;Cochrane Database of Systematic Reviews;2023-01-10

5. The role of pioglitazone in the fight against insulin resistance, atherosclerosis, cardiovascular disease, and non-alcoholic fatty liver disease;Diabetes mellitus;2022-11-30